The interim results for the I-WISh survey undertaken by Novartis, which collaborated with 480 health care providers across 13 countries, found that a high percentage of patients with Immune Thrombocytopenia experienced negative impacts to their quality of life due to the immune disease.
Many patients who have ITP have either undergone a splenectomy, or it’s part of the discussion around treatment. If you’re in Victoria, Tasmania and Queensland, you are added to their register to receive regular updates and information. Check out what their latest Health Update has to say.
At the end of March 2018, more than 30 people travelled from across the country to attend the first PDSA Regional Meeting in Melbourne, Victoria.